Citation Impact
Citing Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Untangling the ErbB signalling network
2001 Standout
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.
1998
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
2008 StandoutNobel
High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis?
2008
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
2002 Standout
PR1 vaccination in myeloid malignancies
2008
Atopic Dermatitis
2008 Standout
mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies
2003
Gold Catalysis
2006 Standout
Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma
1999
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Catalytic Carbophilic Activation: Catalysis by Platinum and Gold π Acids
2007 Standout
Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes
2005
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
The Measure of All Rings—N‐Heterocyclic Carbenes
2010 Standout
Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti‐OX40 and anti‐4‐1BB monoclonal antibodies induces T cell–mediated protective immunity in Her‐2/neu transgenic mice
2005
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
2008
Lung Cancer
2008 Standout
Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs
2002 StandoutNobel
Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer
2006
Cancer immunotherapy via dendritic cells
2012 Standout
In-gel digestion for mass spectrometric characterization of proteins and proteomes
2006 Standout
Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer
2007
The molecular biology of head and neck cancer
2010 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
The cornified envelope: a model of cell death in the skin
2005 Standout
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Strategies for immunotherapy of cancer
2000
Cathepsin D—Many functions of one aspartic protease
2008
Immunomodulatory Properties of Defensins and Cathelicidins
2006
Supported gold nanoparticles as catalysts for organic reactions
2008 Standout
Cathepsin D in the Tumor Microenvironment of Breast and Ovarian Cancers
2020
Antimicrobial peptides: therapeutic potential
2006
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
2006 Standout
APD3: the antimicrobial peptide database as a tool for research and education
2015 Standout
Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.
2002
Dendritic Cell Vaccines for Cancer Immunotherapy
1999
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Gold-Catalyzed Efficient Formation of Alkenyl Enol Esters/Carbonates from Trimethylsilylmethyl-Substituted Propargyl Esters/Carbonates
2006
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Synthesis, Characterization and Reactivity of N-Heterocyclic Carbene Gold(III) Complexes
2007
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Hydroamination: Direct Addition of Amines to Alkenes and Alkynes
2008 Standout
Dendritic Cell-Based Vaccination in Solid Cancer
2002
Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis
2007
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Gold-Catalyzed Cycloisomerizations of Enynes: A Mechanistic Perspective
2008 Standout
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Gold(I)-Catalyzed Domino Ring-Opening Ring-Closing Hydroamination of Methylenecyclopropanes (MCPs) with Sulfonamides: Facile Preparation of Pyrrolidine Derivatives
2006
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Ligand Effects in Homogeneous Au Catalysis
2008 Standout
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
Human Antimicrobial Peptides and Proteins
2014
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Rapid Validation of Protein Identifications with the Borderline Statistical Confidence via De Novo Sequencing and MS BLAST Searches
2006
Alternative Synthetic Methods through New Developments in Catalysis by Gold
2008 Standout
From σ- to π-Electrophilic Lewis Acids. Application to Selective Organic Transformations
2007
Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma
2003 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Intermolecular Hydroamination of Methylenecyclopropane Catalyzed by Group IV Metal Complexes
2007
Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor
2000
Immunobiology of Dendritic Cells
2000 Standout
Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.
1999
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Gold-Catalyzed Carbon−Heteroatom Bond-Forming Reactions
2011 Standout
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Gold-Catalyzed Organic Reactions
2007 Standout
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Gold-Catalyzed Organic Transformations
2008 Standout
Cutting Edge: Inhibition of Experimental Tumor Metastasis by Dendritic Cells Pulsed with α-Galactosylceramide
1999
Rational approaches to human cancer immunotherapy
2003
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
2001
Deficiency of Dermcidin-Derived Antimicrobial Peptides in Sweat of Patients with Atopic Dermatitis Correlates with an Impaired Innate Defense of Human Skin In Vivo
2005
Gold(I)-Catalyzed Activation of Alkynes for the Construction of Molecular Complexity
2015 Standout
Induction of Primary Human T Cell Responses against Hepatitis C Virus-Derived Antigens NS3 or Core by Autologous Dendritic Cells Expressing Hepatitis C Virus Antigens: Potential for Vaccine and Immunotherapy
2006
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Thomas Flad being referenced
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
1998
Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients
2004
Direct Protein Identification from Nonspecific Peptide Pools by High‐Accuracy MS Data Filtering
2006
Detection of dermcidin-derived peptides in sweat by ProteinChip® Technology
2002
Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis
2005
A novel MHC-associated Proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias
2006
Cathepsin S Activity is Detectable in Human Keratinocytes and is Selectively Upregulated upon Stimulation with Interferon-γ
2002
Cathepsin D Is Present in Human Eccrine Sweat and Involved in the Postsecretory Processing of the Antimicrobial Peptide DCD-1L
2005
Human α-Defensins HNPs-1, -2, and -3 in Renal Cell Carcinoma
2002
Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
2005
Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.
1998
Direct identification of MHC class I bound tumor-associated peptide antigens of a renal carcinoma cell line
1997